118 related articles for article (PubMed ID: 8591697)
1. Elevated ratio of summed serum proinsulin to insulin response after oral glucose load in type 2 diabetes decreases following sulfonylurea treatment.
Kumakura S; Iwamoto Y; Kuzuya T; Shiraishi I; Matsuda A; Saito T
Diabetes Res Clin Pract; 1995 Aug; 29(2):107-12. PubMed ID: 8591697
[TBL] [Abstract][Full Text] [Related]
2. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
3. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Yoshioka N; Kuzuya T; Matsuda A; Taniguchi M; Iwamoto Y
Diabetologia; 1988 Jun; 31(6):355-60. PubMed ID: 3046976
[TBL] [Abstract][Full Text] [Related]
4. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Ohkura T; Inoue K; Fujioka Y; Nakanishi R; Shiochi H; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Ohkura H; Kato M; Yamamoto K; Taniguchi S
BMC Res Notes; 2013 Nov; 6():453. PubMed ID: 24215809
[TBL] [Abstract][Full Text] [Related]
5. Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM.
Yoshioka N; Kuzuya T; Matsuda A; Iwamoto Y
Diabetes; 1989 Feb; 38(2):262-6. PubMed ID: 2644145
[TBL] [Abstract][Full Text] [Related]
6. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
7. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
Goetz FC; French LR; Thomas W; Gingerich RL; Clements JP
Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300
[TBL] [Abstract][Full Text] [Related]
8. Secondary sulphonylurea failure: what pathogenesis is responsible?
Chen YN; Chen SY; Zeng LJ; Ran JM; Xie B; Wu MY; Wu YZ
Br J Biomed Sci; 2003; 60(1):9-13. PubMed ID: 12680624
[TBL] [Abstract][Full Text] [Related]
9. The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
Pfützner A; Lorra B; Abdollahnia MR; Kann PH; Mathieu D; Pehnert C; Oligschleger C; Kaiser M; Forst T
Diabetes Technol Ther; 2006 Jun; 8(3):375-84. PubMed ID: 16800759
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.
Shiraishi I; Iwamoto Y; Kuzuya T; Matsuda A; Kumakura S
Diabetologia; 1991 Oct; 34(10):737-41. PubMed ID: 1959706
[TBL] [Abstract][Full Text] [Related]
11. Progressive decrease of proinsulin secretion in sulphonylurea-treated type 2 diabetes.
Chen YN; Chen SY; Zeng LJ; Ran JM; Wu MY
Br J Biomed Sci; 2005; 62(1):5-8. PubMed ID: 15816204
[TBL] [Abstract][Full Text] [Related]
12. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Røder ME; Porte D; Schwartz RS; Kahn SE
J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
[TBL] [Abstract][Full Text] [Related]
13. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes.
Panahloo A; Mohamed-Ali V; Andrés C; Denver AE; Yudkin JS
Metabolism; 1998 Jun; 47(6):637-43. PubMed ID: 9627359
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
Diabet Med; 1994 Apr; 11(3):293-8. PubMed ID: 8033529
[TBL] [Abstract][Full Text] [Related]
16. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
[TBL] [Abstract][Full Text] [Related]
17. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
[TBL] [Abstract][Full Text] [Related]
18. Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
Festa A; Shnawa N; Schernthaner G; Haffner SM
Exp Clin Endocrinol Diabetes; 1999; 107(7):447-52. PubMed ID: 10595596
[TBL] [Abstract][Full Text] [Related]
19. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
Coifman R; Dalbosco IS; Russo EM; Moisés RS
Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
[TBL] [Abstract][Full Text] [Related]
20. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
